DK272688A - Vaccine og fremgangsmaade til fresmtilling deraf - Google Patents

Vaccine og fremgangsmaade til fresmtilling deraf

Info

Publication number
DK272688A
DK272688A DK272688A DK272688A DK272688A DK 272688 A DK272688 A DK 272688A DK 272688 A DK272688 A DK 272688A DK 272688 A DK272688 A DK 272688A DK 272688 A DK272688 A DK 272688A
Authority
DK
Denmark
Prior art keywords
vaccine
procedures
processing
Prior art date
Application number
DK272688A
Other languages
Danish (da)
English (en)
Other versions
DK272688D0 (da
Inventor
Robert L Hunter
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of DK272688D0 publication Critical patent/DK272688D0/da
Publication of DK272688A publication Critical patent/DK272688A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK272688A 1986-09-22 1988-05-18 Vaccine og fremgangsmaade til fresmtilling deraf DK272688A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90996486A 1986-09-22 1986-09-22
US7518787A 1987-07-16 1987-07-16
PCT/US1987/002056 WO1988001873A1 (en) 1986-09-22 1987-08-19 Vaccine and method of preparation

Publications (2)

Publication Number Publication Date
DK272688D0 DK272688D0 (da) 1988-05-18
DK272688A true DK272688A (da) 1988-07-12

Family

ID=26756538

Family Applications (1)

Application Number Title Priority Date Filing Date
DK272688A DK272688A (da) 1986-09-22 1988-05-18 Vaccine og fremgangsmaade til fresmtilling deraf

Country Status (17)

Country Link
EP (1) EP0283505B1 (fi)
JP (1) JPH01501064A (fi)
KR (1) KR920002165B1 (fi)
CN (1) CN1030019A (fi)
AP (1) AP8700068A0 (fi)
AT (1) ATE108067T1 (fi)
BR (1) BR8707471A (fi)
CA (1) CA1322721C (fi)
DE (1) DE3750176T2 (fi)
DK (1) DK272688A (fi)
ES (1) ES2007720A6 (fi)
FI (1) FI882397A0 (fi)
GR (1) GR871460B (fi)
IL (1) IL83953A (fi)
NZ (2) NZ236829A (fi)
PT (1) PT85760B (fi)
WO (1) WO1988001873A1 (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0513861B1 (en) * 1987-11-03 1997-02-26 Syntex (U.S.A.) Inc. Vaccine adjuvant comprising a tetra-polyol
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
WO2001085208A2 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
KR20020032772A (ko) * 2000-10-27 2002-05-04 김정우 살모넬라균에 대한 난황항체
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
EP1532167B1 (en) 2002-07-17 2012-01-25 Cytos Biotechnology AG Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
NZ537003A (en) 2002-07-18 2008-03-28 Cytos Biotechnology Ag Hapten-carrier conjugates comprising virus like particles and uses thereof
SI1524994T1 (sl) 2002-07-19 2011-08-31 Cytos Biotechnology Ag Sestavki cepiv, ki vsebujejo amiloidne beta 1-6 antigenske mreĹľe
JP2006503825A (ja) * 2002-09-03 2006-02-02 フォンダシオン ユーロバク アジュバント
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
AU2007224034B2 (en) 2006-03-07 2012-03-29 Vaxinnate Corporation Compositions that include hemagglutinin, methods of making and methods of use thereof
WO2009091692A2 (en) * 2008-01-18 2009-07-23 Aeras Global Tb Vaccine Foundation Malaria vaccine compositions and constituents which elicit cell mediated immunity
WO2009128949A2 (en) 2008-04-18 2009-10-22 Vaxinnate Corporation Compositions of dengue viral proteins and methods of use
US20120171239A1 (en) * 2009-09-03 2012-07-05 Mizel Steven B Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use
CN101914144B (zh) * 2010-04-30 2013-01-09 浙江大学 金黄色葡萄球菌荚膜多糖和蛋白质偶联物及制备方法和用途
CN102580081B (zh) * 2012-02-22 2014-07-02 中国医学科学院医学生物学研究所 Nad、氢氧化铝复合佐剂及含该复合佐剂的疫苗
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US2979528A (en) * 1953-10-19 1961-04-11 Wyandotte Chemicals Corp Nitrogen-containing polyoxyalkylene detergent compositions
US3022335A (en) * 1955-03-30 1962-02-20 Wyandotte Chemicals Corp Surface active polyoxyalkylene compounds having a plurality of heteric polyoxypropylene-polyoxyethylene chains
US3036118A (en) * 1957-09-11 1962-05-22 Wyandotte Chemicals Corp Mixtures of novel conjugated polyoxyethylene-polyoxypropylene compounds
DE2860875D1 (en) * 1977-09-28 1981-10-15 Nat Res Dev Immunological preparations incorporating mhc antigens and their production
DE3063736D1 (en) * 1979-03-27 1983-07-21 Nat Res Dev Improvements in or relating to immunological preparations
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
FR2517967A1 (fr) * 1981-12-10 1983-06-17 Air Liquide Procede de production d'un vaccin biochimique contre les fievres a salmonelles
US4711876A (en) * 1985-12-05 1987-12-08 Catapano Salvatore J Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)

Also Published As

Publication number Publication date
GR871460B (en) 1988-03-21
DK272688D0 (da) 1988-05-18
IL83953A (en) 1992-05-25
KR920002165B1 (ko) 1992-03-19
EP0283505B1 (en) 1994-07-06
PT85760A (en) 1987-10-01
BR8707471A (pt) 1988-09-13
AU8023287A (en) 1988-04-07
AP8700068A0 (en) 1989-03-21
NZ236829A (en) 1993-07-27
WO1988001873A1 (en) 1988-03-24
DE3750176T2 (de) 1994-10-13
AU629103B2 (en) 1992-09-24
JPH01501064A (ja) 1989-04-13
CN1030019A (zh) 1989-01-04
NZ221868A (en) 1991-03-26
CA1322721C (en) 1993-10-05
FI882397A (fi) 1988-05-20
EP0283505A4 (en) 1989-11-07
EP0283505A1 (en) 1988-09-28
FI882397A0 (fi) 1988-05-20
ES2007720A6 (es) 1989-07-01
IL83953A0 (en) 1988-02-29
AU7113191A (en) 1991-07-11
PT85760B (pt) 1990-08-31
AU613588B2 (en) 1991-08-08
DE3750176D1 (de) 1994-08-11
KR880701560A (ko) 1988-11-03
ATE108067T1 (de) 1994-07-15

Similar Documents

Publication Publication Date Title
DK272688A (da) Vaccine og fremgangsmaade til fresmtilling deraf
DK664887A (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK66988D0 (da) Cholestyraminpraeparat og fremgangsmaade til fremstilling deraf
DK484587A (da) Antioxidant og fremgangsmaade til fremstilling heraf
DK521887A (da) Substituerede pyrazoliner og fremgangsmaade til fremstilling deraf
DK491087A (da) Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf
DK335986D0 (da) Poly-4-aminopropyl-2-carboxamidoderivat og fremgangsmaade til fremstilling deraf
DK330289A (da) Veterinaere indretninger og fremgangsmaade til fremstilling deraf
DK303887D0 (da) Dopamin-beta-hydroxylaseinhibitorer og fremgangsmaade til fremstilling deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK397788D0 (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
NO169679C (no) Fremgangsmaate og system for lokalisering og orientering
NO165421C (no) Fremgangsmaate og anordning for avskinning.
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK251087A (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
DK463987D0 (da) Oprenset enzym og fremgangsmaade til fremstilling heraf
DK290187A (da) Peptidderivater og fremgangsmaade til fremstilling deraf
DK129689D0 (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
DK319188A (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
DK287787A (da) Isoxazolidinonderivater og fremgangsmaade til fremstilling deraf
DK657087A (da) Cholestyraminpraeparater og fremgangsmaade til fremstilling deraf
DK588887D0 (da) Farmaceutisk praeparat og fremgangsmaade til dets fremstilling
DK372885A (da) Vaccine og fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment